In our study, high-throughput RNA sequencing results supported the findings of the referenced studies, showing higher levels of NALT1 in cancer patients, specifically in sEVs isolated from peripheral blood of individuals with CRC. The gene discussed is NALT1; the disease is colorectal carcinoma.